These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 31873735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.
    Bredemeier M, Lopes LM, Eisenreich MA, Hickmann S, Bongiorno GK, d'Avila R, Morsch ALB, da Silva Stein F, Campos GGD.
    BMC Cardiovasc Disord; 2018 Feb 07; 18(1):24. PubMed ID: 29415653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
    White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L, CARES Investigators.
    N Engl J Med; 2018 Mar 29; 378(13):1200-1210. PubMed ID: 29527974
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.
    Liu CW, Chang WC, Lee CC, Shau WY, Hsu FS, Wang ML, Chen TC, Lo C, Hwang JJ.
    Nutr Metab Cardiovasc Dis; 2019 Oct 29; 29(10):1011-1022. PubMed ID: 31378626
    [Abstract] [Full Text] [Related]

  • 9. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED.
    Drugs Aging; 2017 May 29; 34(5):401-410. PubMed ID: 28425024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.
    Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R.
    Arthritis Rheumatol; 2018 Nov 29; 70(11):1702-1709. PubMed ID: 29869840
    [Abstract] [Full Text] [Related]

  • 12. Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia.
    MacDonald TM, Ford I, Nuki G, Mackenzie IS, De Caterina R, Findlay E, Hallas J, Hawkey CJ, Ralston S, Walters M, Webster J, McMurray J, Perez Ruiz F, Jennings CG, Members of the FAST Study Group.
    BMJ Open; 2014 Jul 10; 4(7):e005354. PubMed ID: 25011991
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X, Du H, Gu J, Zhao D, Jiang L, Li X, Zuo X, Liu Y, Li Z, Li X, Zhu P, Li J, Zhang Z, Huang A, Zhang Y, Bao C.
    Int J Rheum Dis; 2014 Jul 10; 17(6):679-86. PubMed ID: 24467549
    [Abstract] [Full Text] [Related]

  • 17. `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea.
    Jeong H, Choi E, Suh A, Yoo M, Kim B.
    Rheumatol Int; 2023 Feb 10; 43(2):265-281. PubMed ID: 36346443
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Febuxostat versus allopurinol for gout.
    Gelber AC.
    N Engl J Med; 2006 Apr 06; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract] [Full Text] [Related]

  • 20. Cardiovascular safety of febuxostat versus allopurinol among the Asian patients with or without gout: A systematic review and meta-analysis.
    Deng JH, Lai PH, Xie LS, Qiu SS, Qiu DS, Zhang JX.
    Clin Transl Sci; 2024 Mar 06; 17(3):e13757. PubMed ID: 38488426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.